Scientific Milestones and Learnings 2024 - Chan Zuckerberg Initiative
webThis is a philanthropic organization's year-in-review update, tangentially relevant to AI safety insofar as it illustrates how large-scale AI capabilities are being deployed in high-stakes biomedical domains outside traditional AI safety oversight frameworks.
Metadata
Importance: 18/100blog postnews
Summary
A video discussion featuring CZI leadership reflecting on 2024 milestones in AI-powered biomedical research, including the release of AI cell model platforms and real-time inflammation biosensors. The conversation highlights CZI's progress toward its mission of curing, preventing, or managing all diseases by the end of the century through tools like virtual cell models and large-scale computing infrastructure.
Key Points
- •CZI released a platform enabling researchers to access AI-powered cell models, advancing the concept of a 'virtual cell' for biological research.
- •CZ Biohub Chicago debuted a first-of-its-kind sensor to monitor inflammation in real-time, representing a tangible biomedical hardware milestone.
- •CZI is building one of the largest nonprofit computing systems to support AI-accelerated biomedical research.
- •The discussion frames AI and software tools as central to accelerating breakthroughs toward curing or managing all diseases.
- •Leadership emphasized the intersection of biology, AI, and data infrastructure as key levers for scientific progress.
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| Chan Zuckerberg Initiative | Organization | 50.0 |
Cached Content Preview
HTTP 200Fetched Apr 9, 20262 KB
Our Scientific Achievements, Learnings and Future Vision Skip to content Jan 16, 2025 · 1 min read Watch: Priscilla Chan on CZI’s Science Milestones and What’s Next Tags: Science , Technology Share A s we welcome the new year, CZI Co-Founder and Co-CEO Priscilla Chan sat down with Patricia Brennan, vice president of science technology and general manager for science at CZI, and Shana Kelley, president of the Chan Zuckerberg Biohub Chicago, to reflect on the progress made over the past year in building tools to better understand and measure disease — and the exciting work still ahead. From releasing a platform for researchers and biologists to easily access state-of-the-art AI-powered cell models to debuting the Chicago Biohub’s first-of-its-kind sensor to monitor inflammation in real-time , the conversation highlighted tangible work towards accelerating biomedical research and demonstrating progress toward CZI’s mission to cure, prevent or manage all diseases by the end of the century. Read more: 2024 in Review: How AI Shaped a Year of Impact at CZI Share RELATED ARTICLES SCIENCE Accelerating AI in Biology With Community-Driven Benchmarks SCIENCE 4 Ways Protein Monitoring Could Change the Way We Stay Healthy Sign Up For Updates Sorry, marketing cookies are required to view this form. We use cookies to help us improve the site and to inform our marketing and digital content efforts. If you choose ‘Don’t Enable,’ sites you’re logged into – like Facebook and Twitter – may still be able to identify you as a visitor to this site. Learn more . Don't Enable Accept
Resource ID:
636016fabc119578 | Stable ID: sid_3SnCN60Ws1